All In Biotech

Drug Trial Radar · NCT05734521

Avalglucosidase Alfa Pregnancy Study

A Descriptive Safety Study Based on Data Collected From Women and Their Offspring Exposed to Nexviazyme/Nexviadyme (Avalglucosidase Alfa-ngpt/Avalglucosidase Alfa) During Pregnancy and/or Lactation in the Postmarketing Setting

Last checked: Nov 20, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Oct 26, 2022

Primary completion

Oct 31, 2032

Study completion Oct 31, 2032

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Feb 21, 2023

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a worldwide, descriptive safety study collecting data on women and their offspring exposed to avalglucosidase alfa during pregnancy and/or lactation, to assess the risks of avalglucsodiase alfa on pregnancy and maternal complications and adverse effects in the developing fetus, neonate, and infant. * Outcomes in exposed infants, including growth and development, will be assessed through at least the first year of life. * Data will be collected for approximately 10 years.

Conditions

  • Pompe Disease
  • Pregnancy

Interventions

  • avalglucosidase alfa-NGPT (GZ402666) IVBiological

    intravenous infusion

  • avalglucosidase alfa-NGPT (GZ402666)Biological

    exposed via pregnancy and lactation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maternal complicationsTime frame: through study completion, an average of 10 years
  2. Pregnancy outcomeTime frame: through study completion, an average of 10 years
  3. Infant outcomeTime frame: through study completion, an average of 10 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Investigational site worldwide

    Bridgewater, New Jersey · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.